These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 6947981)
1. Anti-Ia reactivity in sera from patients with systemic lupus erythematosus. Okudaira K; Searles RP; Ceuppens JL; Goodwin JS; Williams RC J Clin Invest; 1982 Jan; 69(1):17-24. PubMed ID: 6947981 [TBL] [Abstract][Full Text] [Related]
2. Anti-Ia reactivity in sera from subjects with Entamoeba histolytica infection. De Simone C; Cilli A; Zanzoglu S; Vullo V; Delia S; Sorice F Trans R Soc Trop Med Hyg; 1984; 78(1):64-8. PubMed ID: 6200968 [TBL] [Abstract][Full Text] [Related]
4. Ia specific antilymphocyte antibodies in rheumatoid arthritis. Searles RP; Okudaira K; Savage SM; Goodwin JS Arthritis Rheum; 1983 Apr; 26(4):486-93. PubMed ID: 6340699 [TBL] [Abstract][Full Text] [Related]
5. OKT4+ T cell abnormality in patients with active systemic lupus erythematosus: HLA-DR antigen expressions. Raziuddin S; Danial HB; Kelley M Clin Immunol Immunopathol; 1988 Jul; 48(1):42-9. PubMed ID: 3260161 [TBL] [Abstract][Full Text] [Related]
6. T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus. Okudaira K; Searles RP; Tanimoto K; Horiuchi Y; Williams RC J Clin Invest; 1982 Apr; 69(4):1026-38. PubMed ID: 6978891 [TBL] [Abstract][Full Text] [Related]
7. Characterization of warm-reactive IgG anti-lymphocyte antibodies in systemic lupus erythematosus. Relative specificity for mitogen-activated T cells and their soluble products. Litvin DA; Cohen PL; Winfield JB J Immunol; 1983 Jan; 130(1):181-6. PubMed ID: 6600174 [TBL] [Abstract][Full Text] [Related]
8. Functional property of Ia-positive T cells in peripheral blood from patients with systemic lupus erythematosus. Koide J Scand J Immunol; 1985 Nov; 22(5):577-84. PubMed ID: 3878581 [TBL] [Abstract][Full Text] [Related]
9. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies. Jucaud V; Ravindranath MH; Terasaki PI; Morales-Buenrostro LE; Hiepe F; Rose T; Biesen R Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212 [TBL] [Abstract][Full Text] [Related]
10. Antibodies to HLA-E in nonalloimmunized males: pattern of HLA-Ia reactivity of anti-HLA-E-positive sera. Ravindranath MH; Kaneku H; El-Awar N; Morales-Buenrostro LE; Terasaki PI J Immunol; 2010 Aug; 185(3):1935-48. PubMed ID: 20610644 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the alloactivated E+Ia+ cell capable of stimulating in mixed lymphocyte culture. Shen HH; Irigoyen O; Friedman SM; Chess L J Immunol; 1982 Jan; 128(1):501-5. PubMed ID: 6459379 [TBL] [Abstract][Full Text] [Related]
12. Relationship of anti-beta 2-microglobulin antibodies to T11 and T-cell activation in systemic lupus erythematosus. Croghan TW; Minota S; Yamada A; Winfield JB Clin Immunol Immunopathol; 1985 Nov; 37(2):179-90. PubMed ID: 3899432 [TBL] [Abstract][Full Text] [Related]
13. "Anti-Ia reactivity in sera from patients with chronic active hepatitis (CAH)". Levrero M; Barnaba V; Paroli M; Valesini G; Franco A; Laghi V; Cauda R; Balsano F J Clin Lab Immunol; 1987 Oct; 24(2):63-8. PubMed ID: 2963916 [TBL] [Abstract][Full Text] [Related]
14. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583 [TBL] [Abstract][Full Text] [Related]
15. Increased frequency of class I and II anti-human leukocyte antigen antibodies in systemic lupus erythematosus and scleroderma and associated factors: a comparative study. Tozkir H; Pamuk ON; Duymaz J; Gurkan H; Yazar M; Sari G; Tanrikulu H; Pamuk GE Int J Rheum Dis; 2016 Dec; 19(12):1304-1309. PubMed ID: 25292400 [TBL] [Abstract][Full Text] [Related]
16. Studies on human blood lymphocytes with iC3b (type 3) complement receptors. I. Granular, Fc-IgG receptor positive and negative subsets in healthy subjects and patients with systemic lupus erythematosus. Bakke AC; Gray JD; Abo W; Quismorio FP; Lash A; Cooper SM; Horwitz DA J Immunol; 1986 Feb; 136(4):1253-9. PubMed ID: 2935574 [TBL] [Abstract][Full Text] [Related]
17. Augmentation of anti-HLA-E antibodies with concomitant HLA-Ia reactivity in IFNγ-treated autologous melanoma cell vaccine recipients. Ravindranath MH; Selvan SR; Terasaki PI J Immunotoxicol; 2012; 9(3):282-91. PubMed ID: 22283601 [TBL] [Abstract][Full Text] [Related]
18. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases. Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579 [TBL] [Abstract][Full Text] [Related]
19. Neuronal BC RNA Transport Impairments Caused by Systemic Lupus Erythematosus Autoantibodies. Muslimov IA; Iacoangeli A; Eom T; Ruiz A; Lee M; Stephenson S; Ginzler EM; Tiedge H J Neurosci; 2019 Sep; 39(39):7759-7777. PubMed ID: 31405929 [TBL] [Abstract][Full Text] [Related]
20. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus. Anderson CL; Stillman WS J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]